Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 040708
Company: CHARTWELL MOLECULAR

Products on ANDA 040708

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LIDOCAINE HYDROCHLORIDE VISCOUS	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION;ORAL	Prescription	AT	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 040708

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/27/2007	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/02/2018	SUPPL-7	Labeling-Package Insert		Label is not available on this site.
12/01/2014	SUPPL-6	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 040708

LIDOCAINE HYDROCHLORIDE VISCOUS

SOLUTION;ORAL; 2%
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LIDOCAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION;ORAL	Prescription	No	AT	216780	RUBICON
LIDOCAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION;ORAL	Prescription	No	AT	087872	WOCKHARDT BIO AG
LIDOCAINE HYDROCHLORIDE VISCOUS	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION;ORAL	Prescription	No	AT	040708	CHARTWELL MOLECULAR
LIDOCAINE HYDROCHLORIDE VISCOUS	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION;ORAL	Prescription	No	AT	218138	PAI HOLDINGS PHARM
LIDOCAINE VISCOUS	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION;ORAL	Prescription	No	AT	088802	HIKMA